SCHEMBL3764574

SCHEMBL3764574

Fc1cccc(-c2csc(Br)n2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.70
MAPT P10636 2/20 0.70
MEN1 O00255 1/20 0.70
KMT2A Q03164 1/20 0.70
ALDH1A1 P00352 3/20 0.56
HPGD P15428 2/20 0.51
HK1 P19367 1/20 0.51
RAB9A P51151 1/20 0.51
HKDC1 Q2TB90 1/20 0.51
GRM5 P41594 1/20 0.50
CYP1A1 P04798 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP1B1 Q16678 2/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
IDO1 P14902 1/20 0.45
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
AMY1A P0DUB6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6699384 0.82 MEN1 (1.00) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL4076416 0.81 ALDH1A1 (0.74) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL28932584 0.81 KDM4E (0.68) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL9955922 0.81 KDM4E (0.68) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL8700799 0.81 KDM4E (0.68) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL19196250 0.80 ALDH1A1 (0.53) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL3765806 0.79 CYP19A1 (0.60) MAPTALDH1A1HPGDHK1RAB9A
SCHEMBL30087395 0.79 ATP4A (0.57) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL25735690 0.79 TSHR (0.68) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL3767170 0.79 ATP4A (0.57) KDM4EMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
CN-101103007-A Amide compound TAKEDA PHARMACEUTICAL (JP) 2008-01-09 CN disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 KDM4E 1547/4885MAPT 3805/4885MEN1 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.